Clinical Trial Update: Hypovitaminosis D in Neurocritical Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial on vitamin D supplementation for neurocritical patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Craniocerebral Trauma
• Critical Illness
• Intracranial Aneurysm
• Intracranial Hemorrhages
• Meningitis
• Seizures
• Spinal Cord Injuries
• Stroke
• Vitamin Deficiency

Snippet

Sponsor: University of Utah | Conditions: Craniocerebral Trauma, Intracranial Aneurysm | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-08-17